INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver cancer drug trial halted early – what happened?
Disease control TerminatedThis study tested a drug called SD-101, given directly into the liver, along with standard immunotherapy, for people with two types of liver cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma). The goal was to see if the combination was safe and could shrink tum…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TriSalus Life Sciences, Inc. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New scan could help doctors plan better liver cancer treatments
Knowledge-focused TerminatedThis study tested a special type of scan (SPECT/CT) that uses a safe radioactive tracer to measure how well the liver is working in people with liver cancer. The goal was to see if this scan can track changes in liver function during radiation or surgery. 41 adults with liver can…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC